HemoCue is a global leader in a field of diagnostics known as near-patient, or point‐of‐care, testing. The company offers point‐of‐care tests for glucose, urine albumin and HbA1c as well as total and differential white blood cell count.
Since its founding in 1982, HemoCue has operated under the credo “It must be possible” to deliver a continuous stream of innovations designed to help physicians, nurses and labs -- and save lives in the process. HemoCue introduced hemoglobin photometers, the first system making accurate hemoglobin testing possible in near‐patient settings. Since then, more than 400,000 HemoCue systems have been sold worldwide, to the benefit of millions of patients. Today, four HemoCue tests are performed every second worldwide. HemoCue joined the Danaher portfolio in 2013.